WHO Reports Major Progress Against HIV as New Infections Fall Over 40% Since 2010
The continued decline in new HIV infections demonstrates that sustained investment in prevention, early diagnosis, and access to antiretroviral therapy can deliver measurable public health gains. However, persistent funding gaps, unequal healthcare access, and social stigma remain major barriers. Expanding affordable treatment, strengthening community-based prevention programs, and supporting medical innovation will be essential to achieving the global goal of ending AIDS as a public health threat by 2030.
The global fight against HIV has achieved one of its most encouraging milestones in recent years, with new HIV infections falling by more than 40% worldwide since 2010, according to the latest assessment released by the World Health Organization (WHO). The report highlights significant advances in prevention, treatment, and public health programs while warning that funding shortages, regional inequalities, and healthcare disruptions continue to threaten future progress.
According to WHO, approximately 1.3 million people acquired HIV in 2024, compared with about 2.2 million new infections in 2010. During the same period, AIDS-related deaths have also declined substantially, reflecting expanded access to life-saving antiretroviral therapy (ART).
Decades of Scientific Progress
Health experts attribute the decline to sustained international investment in HIV prevention and treatment. Expanded HIV testing, wider availability of antiretroviral medicines, improved public awareness campaigns, and stronger prevention strategies have helped millions of people avoid infection or live longer, healthier lives.
One of the biggest breakthroughs has been the widespread use of ART, which not only improves the health of people living with HIV but also dramatically reduces the risk of transmitting the virus to others.
By the end of 2025, WHO estimates that around 32 million people worldwide were receiving HIV treatment.
Treatment Access Continues to Expand
Modern HIV treatment has transformed what was once considered a fatal disease into a manageable long-term condition for many patients.
People who begin treatment early and continue taking medication regularly can often maintain healthy immune systems and enjoy near-normal life expectancy.
Healthcare providers also emphasize that individuals receiving effective treatment can significantly reduce the likelihood of passing HIV to sexual partners.
Prevention Remains a Priority
Although progress has been remarkable, WHO stresses that prevention remains essential.
Health authorities continue promoting:
- Regular HIV testing
- Safe sexual practices
- Condom use
- Pre-exposure prophylaxis (PrEP)
- Prevention of mother-to-child transmission
- Early diagnosis and immediate treatment
Researchers are also optimistic about new long-acting HIV prevention medicines that may simplify protection for people at higher risk of infection.
Millions Still Need Care
Despite global progress, major gaps remain.
WHO estimates that around 41 million people were living with HIV by the end of 2025, and approximately 9 million people still lacked access to life-saving treatment.
Many low-income countries continue to face shortages of medicines, healthcare workers, laboratory services, and financial resources needed to expand HIV programs.
Regional Differences Persist
The epidemic is evolving differently across regions.
Several countries in sub-Saharan Africa have achieved major reductions in new HIV infections through sustained public health investment. However, infections continue rising in some parts of Eastern Europe, Central Asia, Latin America, and the Middle East, where stigma, limited healthcare access, and social inequalities continue to affect prevention efforts.
WHO also notes that key populations—including sex workers, people who inject drugs, transgender people, men who have sex with men, and prison populations—continue to face disproportionately higher infection risks.
Funding Challenges Threaten Progress
Public health experts warn that financial pressures could slow or even reverse decades of progress.
Recent reductions in international HIV funding have affected prevention services, community outreach, HIV testing, and access to medicines in several countries.
Health organizations say sustained investment will be essential if the world hopes to meet the goal of ending AIDS as a public health threat by 2030.
Innovation Offers Hope
Scientists continue developing new technologies that could further reduce HIV transmission.
Long-acting injectable medications, improved diagnostic tools, and expanded community-based healthcare programs are expected to strengthen prevention efforts over the coming years.
Researchers believe these innovations, combined with affordable access and stronger healthcare systems, could significantly reduce future infections worldwide.
Looking Ahead
The WHO says the decline in new HIV infections demonstrates that coordinated global action can deliver measurable public health improvements. However, maintaining that momentum will require continued political commitment, financial investment, and efforts to reduce stigma and discrimination.
Health officials stress that every person should have access to testing, treatment, prevention services, and accurate health information regardless of where they live.
Conclusion
More than four decades after HIV first emerged as a global health crisis, the world has achieved remarkable progress in reducing new infections and expanding treatment. A decline of over 40% in new HIV infections since 2010 represents a major public health success. Yet millions of people still require care, and funding challenges threaten future gains. Continued international cooperation, medical innovation, and equitable healthcare access will be critical to moving closer to the goal of ending AIDS as a public health threat by 2030.
